10-Q: HCMC Reports Widened Net Loss, Ineffective Controls

Healthier Choices Management Corp. reported a widened net loss from continuing operations and identified material weaknesses in its internal controls for the quarter ended September 30, 2025.

Summary

• Net loss from continuing operations for the nine months ended September 30, 2025, worsened to $(6,251,586) compared to $(5,939,295) in the prior year.
• The company reported negative gross profit of $(22,333) for the nine months ended September 30, 2025, as cost of sales ($25,312) significantly exceeded net sales ($2,979).
• Cash and cash equivalents decreased to $1,121,597 as of September 30, 2025, from $1,193,567 at December 31, 2024.
• Working capital was negative $3.5 million as of September 30, 2025, a deterioration from negative $1.56 million at December 31, 2024.
• Management concluded that disclosure controls and procedures and internal control over financial reporting were ineffective as of September 30, 2025, citing material weaknesses including lack of documented controls, segregation of duties, and IT controls.
• The company is a holding company focused on monetizing its intellectual property, including Q-Cup technology and Imitine, following the spin-off of its grocery business (HCWC) on September 13, 2024.
• A patent infringement lawsuit against R.J. Reynolds Vapor Company is ongoing, with an inter partes review filed by RJR at the USPTO, and a decision on institution expected after January 2025.

Sentiment

Score: 2

Explanation: The company reported worsening net losses and negative gross profit from continuing operations, coupled with a deteriorating working capital position and increased cash burn. The explicit 'going concern' warning and identified material weaknesses in internal controls indicate severe financial and operational challenges. While there's a strategic focus on IP, its monetization remains highly uncertain and costly, as evidenced by ongoing litigation and past dismissals. The reliance on related party funding further underscores financial fragility.

Positives

• Operating expenses for the nine months ended September 30, 2025, slightly decreased to $6.2 million from $6.3 million in the prior year.
• The company successfully paid off its $453,232 line of credit balance in full on January 3, 2025.
• The total net loss (including discontinued operations) for the nine months ended September 30, 2025, improved to $(6,251,586) from $(9,714,854) in the prior year, primarily due to the spin-off of the loss-making grocery segment.
• The U.S. Court of Appeals for the Federal Circuit previously ruled in favor of HCMC on two appeals in its patent infringement action against Philip Morris, reversing prior dismissals and attorney fee awards, though this case was later voluntarily dismissed by HCMC.

Negatives

• Net loss from continuing operations widened to $(6,251,586) for the nine months ended September 30, 2025, compared to $(5,939,295) for the same period in 2024.
• Gross profit was negative $(22,333) for the nine months ended September 30, 2025, indicating that cost of sales exceeded net sales.
• The company reported negative working capital of $3.5 million as of September 30, 2025, a significant deterioration from $1.56 million at December 31, 2024.
• Cash used in operating activities increased to $(3,058,181) for the nine months ended September 30, 2025, from $(2,033,153) in the prior year.
• A significant increase in "Due to related party" to $3,177,907 as of September 30, 2025, from $190,268 at December 31, 2024, indicates reliance on HCWC for funding.
• The company's internal control over financial reporting and disclosure controls and procedures were deemed ineffective, with material weaknesses identified.
• The patent infringement lawsuit against Philip Morris was voluntarily dismissed by HCMC on December 31, 2024, after a Federal Circuit ruling denied HCMC's appeal regarding the patent's patentability.

Risks

• The company has historically reported net losses and cash outflows from operations, raising a going concern uncertainty.
• Ability to successfully implement plans to reduce costs and secure additional capital from outside investors is not assured.
• There is no assurance that the company will be awarded patents for its pending patent applications or that it can monetize existing patents.
• Dependence on third-party manufacturers for products (vaporizer e-liquid and accessories) poses a risk of supply interruption or inconsistency.
• The company's cash and cash equivalents are concentrated in one financial institution, exceeding FDIC coverage limits.
• The ongoing patent infringement lawsuit against R.J. Reynolds Vapor Company faces an inter partes review at the USPTO, with an uncertain outcome.
• Material weaknesses in internal control over financial reporting and ineffective disclosure controls and procedures pose risks to financial reporting reliability.

Future Outlook

Management believes its cash on hand and its ability to draw on its $5 million line of credit will enable the company to meet its obligations and capital requirements for at least the twelve months from September 30, 2025. The company expects to continue incurring losses for the foreseeable future and is working to reduce costs and secure additional capital, though success is not assured. A decision on the institution of an inter partes review for the R.J. Reynolds patent lawsuit is expected sometime after January 2025.

Management Comments

• Management has made plans to reduce certain costs and raise needed capital, however there can be no assurance the Company can successfully implement these plans.
• The Company believes its cash on hand and its ability to draw on its $5 million line of credit will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date as of September 30, 2025.
• Management continues to work to improve its controls related to our material weaknesses listed above.
• We are currently working to improve and simplify our internal processes and implement enhanced controls, as discussed above, to address the material weaknesses in our internal control over financial reporting and to remedy the ineffectiveness of our disclosure controls and procedures.

Industry Context

HCMC operates in the intellectual property monetization and vaping market, a sector characterized by intense competition and evolving regulatory landscapes. The company's focus on patent enforcement and its Q-Cup technology positions it within the cannabis/CBD concentrate vaping niche. The spin-off of its grocery business indicates a strategic shift to focus solely on its IP assets. The ongoing patent litigation against major players like R.J. Reynolds highlights the competitive and legally complex nature of protecting intellectual property in this industry.

Comparison to Industry Standards

• The company's negative gross profit and significant net losses are well below industry standards for profitable technology or consumer product companies.
• The identified material weaknesses in internal controls and ineffective disclosure controls are a serious governance concern, contrasting sharply with best practices for publicly traded companies, especially those with complex IP portfolios.
• The reliance on related party funding and the explicit "going concern" warning are indicators of financial distress, which is not typical for healthy, growing companies in the technology or consumer goods sectors.
• The protracted and ultimately dismissed patent litigation against Philip Morris, followed by a new suit against R.J. Reynolds, suggests a high-cost, high-risk strategy for IP monetization, which may not be sustainable compared to companies with diversified revenue streams or stronger market positions.

Corporate Governance

Legal Proceedings

• One lawsuit related to alleged battery defects for an electronic cigarette device was dismissed, with the plaintiff settling with the company's insurance carrier, resulting in no economic impact to HCMC.
• A second lawsuit related to alleged battery defects was resolved, with HCMC paying $1.5 million as of September 30, 2025.
• The patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A., initially filed on November 30, 2020, was voluntarily dismissed by HCMC on December 31, 2024, following a Federal Circuit ruling that denied HCMC's appeal regarding the patent's patentability.
• A patent infringement lawsuit against R.J. Reynolds Vapor Company (RJR) was filed on September 26, 2023, alleging infringement by RJR's Vuse electronic cigarette. RJR filed a motion to dismiss on November 17, 2023, which HCMC opposed on December 22, 2023.
• RJR filed an inter partes review (IPR) of the patent-in-suit at the United States Patent and Trademark Office (USPTO) on September 18, 2024, with a decision on institution expected after January 2025.

Related Party Transactions

• HCMC and HCWC (the spun-off grocery business) entered into a Transition Services Agreement (TSA) for transitional services like IT, accounting, HR, and payroll for up to one year following the September 13, 2024 spin-off.
• The "Due to related party" balance increased significantly to $3,177,907 as of September 30, 2025, from $190,268 at December 31, 2024, reflecting continued funding from HCWC to support HCMC's operations during the transition period. These advances are short-term and repayable within 12 months.

Stakeholder Impact

• Shareholders face significant dilution risk from potential future capital raises, continued losses, and the "going concern" uncertainty. The stock price is likely to be negatively impacted by the poor financial performance and internal control issues.
• Employees may experience job insecurity due to the company's financial instability and plans to reduce costs. The identified lack of personnel contributing to internal control weaknesses suggests potential strain on existing staff.
• Creditors face increased credit risk due to the "going concern" warning and deteriorating working capital. The significant "Due to related party" balance indicates reliance on a related entity for liquidity.
• Customers may be affected by the shift from brick-and-mortar vape stores to wholesale and online channels, coupled with challenges in bringing new products to market, which could impact product availability and customer experience.
• Suppliers face potential supply chain risks if HCMC's financial health deteriorates further, impacting their ability to receive timely payments or fulfill orders.

Next Steps

• Management plans to reduce certain costs and raise needed capital.
• The company will continue efforts to monetize its patent suite through development, production, licensing, royalty agreements, and enforcement actions.
• Management is working to improve internal controls by increasing headcount, establishing IT policies, and reviewing third-party SOC reports.
• A decision on the institution of an inter partes review for the R.J. Reynolds patent lawsuit by the USPTO is expected sometime after January 2025.
• The "Completion Date" for Series E Redeemable Convertible Preferred Stock purchasers to acquire Series A Convertible Preferred Stock of HCWC is now set for April 1, 2027.

Key Dates

Recommendation

The filing reveals a company in severe financial distress, marked by worsening net losses, negative gross profit, and a significantly deteriorating working capital position. The explicit 'going concern' warning, coupled with a substantial increase in cash used in operating activities and heavy reliance on related party funding, indicates an unsustainable financial trajectory. Furthermore, the disclosure of ineffective internal controls and material weaknesses raises serious governance and operational red flags. While the company focuses on intellectual property, its monetization strategy has proven costly and uncertain, as evidenced by the dismissal of the Philip Morris lawsuit and the ongoing challenges with R.J. Reynolds. These factors collectively point to a high-risk investment with a strong likelihood of further value erosion.

Keywords

HCMC, Healthier Choices Management Corp, 10-Q, Quarterly Report, Financial Results, Net Loss, Working Capital, Internal Controls, Patent Infringement, Q-Cup Technology, Vaping, Intellectual Property, SEC Filing, Going Concern, HCWC Spin-Off, R.J. Reynolds, Philip Morris